Article citationsMore>>

Sharma, D., Ivanovski, S., Slevin, M., Hamlet, S., Pop, T.S., Brinzaniuc, K., et al. (2013) Bisphosphonate-Related Osteonecrosis of Jaw (BRONJ): Diagnostic Criteria and Possible Pathogenic Mechanisms of an Unexpected Anti-Angiogenic Side Effect. Vascular Cell, 5, 1.
https://doi.org/10.1186/2045-824X-5-1

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.